Response to Gwozdz and colleagues

Ido Weinberg; Michael R. Jaff; Suresh Vedantham

doi:10.1177/1358863X19882743

Response to Gwozdz and colleagues

Ido Weinberg, Michael R. Jaff, Suresh Vedantham

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	90-91
Number of pages	2
Journal	Vascular Medicine (United Kingdom)
Volume	25
Issue number	1
DOIs	https://doi.org/10.1177/1358863X19882743
State	Published - Feb 1 2020

Access to Document

10.1177/1358863X19882743

Cite this

@article{406500565a8a426c82f267cb53dfd944,

title = "Response to Gwozdz and colleagues",

author = "Ido Weinberg and Jaff, {Michael R.} and Suresh Vedantham",

note = "Funding Information: https://orcid.org/0000-0003-4633-5132 Weinberg Ido 1 Jaff Michael R 2 Vedantham Suresh 3 1 Vascular Medicine, Massachusetts General Hospital, Boston, MA, USA 2 Administration, Harvard Medical School, Newton-Wellesley Hospital, Newton, MA, USA 3 Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, MO, USA Ido Weinberg, Vascular Medicine, Massachusetts General Hospital, 55 Fruit St, GB 800, Boston, MA 02114, USA. Email: [email protected] 11 2019 1358863X19882743 {\textcopyright} The Author(s) 2019 2019 SAGE Publications edited-state corrected-proof Declaration of conflicting interests The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: IW – none; MRJ – holds equity in Embolitech and Venarum; uncompensated advisor: Boston Scientific, Cordis Corporation; compensated advisor: Medtronic, Sanofi, BTG; consultant: Volcano/Phillips; SV – grant support from Cook Medical. Funding The authors received no financial support for the research, authorship, and/or publication of this article. ORCID iD Ido Weinberg https://orcid.org/0000-0003-4633-5132 ",

year = "2020",

month = feb,

day = "1",

doi = "10.1177/1358863X19882743",

language = "English",

volume = "25",

pages = "90--91",

journal = "Vascular Medicine (United Kingdom)",

issn = "1358-863X",

number = "1",

}

TY - JOUR

T1 - Response to Gwozdz and colleagues

AU - Weinberg, Ido

AU - Jaff, Michael R.

AU - Vedantham, Suresh

N1 - Funding Information: https://orcid.org/0000-0003-4633-5132 Weinberg Ido 1 Jaff Michael R 2 Vedantham Suresh 3 1 Vascular Medicine, Massachusetts General Hospital, Boston, MA, USA 2 Administration, Harvard Medical School, Newton-Wellesley Hospital, Newton, MA, USA 3 Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, MO, USA Ido Weinberg, Vascular Medicine, Massachusetts General Hospital, 55 Fruit St, GB 800, Boston, MA 02114, USA. Email: [email protected] 11 2019 1358863X19882743 © The Author(s) 2019 2019 SAGE Publications edited-state corrected-proof Declaration of conflicting interests The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: IW – none; MRJ – holds equity in Embolitech and Venarum; uncompensated advisor: Boston Scientific, Cordis Corporation; compensated advisor: Medtronic, Sanofi, BTG; consultant: Volcano/Phillips; SV – grant support from Cook Medical. Funding The authors received no financial support for the research, authorship, and/or publication of this article. ORCID iD Ido Weinberg https://orcid.org/0000-0003-4633-5132

PY - 2020/2/1

Y1 - 2020/2/1

UR - http://www.scopus.com/inward/record.url?scp=85074840871&partnerID=8YFLogxK

U2 - 10.1177/1358863X19882743

DO - 10.1177/1358863X19882743

M3 - Letter

C2 - 31686602

AN - SCOPUS:85074840871

SN - 1358-863X

VL - 25

SP - 90

EP - 91

JO - Vascular Medicine (United Kingdom)

JF - Vascular Medicine (United Kingdom)

IS - 1

ER -

Response to Gwozdz and colleagues

Access to Document

Other files and links

Cite this